Patent ID: 9289380
Filing Date: 2016-03-22
CPC Classification: A61K,A61P

Claim Text:
1. A method of increasing the bioavailability of a salicylanilide anti-parasitic compound in livestock animals comprising: providing a concentration of the salicylanilide anti-parasitic compound to the blood or blood plasma of an animal in excess of 20 ppm, said providing step comprising administering by injection a solution free of precipitate, the solution comprising an effective amount of the salicylanilide anti-parasitic compound in combination with 1% to 35% w/v of a polymeric species selected from the group consisting of polyvinylpyrrolidones, and polyoxypropylene/polyoxyethylene block copolymers, an effective amount of at least one other anti-parasitic compound selected from the group consisting of avermectins and milbemycins and a physiologically acceptable solvent that does not contain either N-methylpyrrolidone or 2-pyrrolidone.